Valuation: CVRx, Inc.

Market Cap 149M 130M 119M 111M 211M 14.15B 214M 1.44B 556M 6.94B 558M 546M 23.91B P/E 2026 *
-2.85x
P/E 2027 * -2.96x
Enterprise Value 174M 152M 140M 130M 247M 16.58B 251M 1.68B 652M 8.13B 654M 640M 28.01B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.85x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.82%
1 week+6.67%
Current month+8.95%
1 month+3.13%
3 months-37.85%
6 months-21.13%
Current year-21.13%
1 week 5.02
Extreme 5.025
6.01
1 month 4.76
Extreme 4.76
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 2024-02-11
Director of Finance/CFO 43 2020-09-30
Chief Operating Officer 57 2025-08-10
Director TitleAgeSince
Director/Board Member 61 2008-09-30
Director/Board Member 57 2020-06-30
Director/Board Member 52 2020-06-30
Date Insider Type Main position Quantity % Market Cap.
05-31Free

Director

65,257 0.2459%
05-31
Treo Ventures LLC
OtherCompany 0 0%
05-31Free

Director

19,902 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%+6.67%-13.31%-63.73% 149M
+0.68%+0.37%+27.56%-7.41% 12.53B
+2.64%+4.27%+65.63%+38.07% 6.23B
+0.99%+2.48%+5.21%+8.39% 5.77B
+2.63%+9.63% - - 4.38B
+2.43%+3.53%-35.24%+9.68% 4.05B
+0.38%+0.34%-26.65%-27.26% 3.85B
+9.00%+14.29%-3.80%-58.55% 1.99B
+2.94%+1.94%+45.22%+246.70% 1.85B
+0.44%+0.17%+55.53%-7.45% 1.54B
Average +2.42%+4.22%+13.35%+15.38% 4.23B
Weighted average by Cap. +1.85%+3.46%+18.41%+11.76%

Financials

2026 *2027 *
Net sales 65.28M 57.05M 52.38M 48.85M 92.61M 6.22B 94.17M 631M 244M 3.05B 245M 240M 10.5B 76.18M 66.56M 61.12M 57M 108M 7.25B 110M 736M 285M 3.56B 286M 280M 12.26B
Net income -52.82M -46.15M -42.38M -39.52M -74.93M -5.03B -76.19M -510M -198M -2.47B -198M -194M -8.5B -52.14M -45.56M -41.84M -39.02M -73.96M -4.96B -75.21M -504M -195M -2.43B -196M -192M -8.39B
Net Debt 25.51M 22.29M 20.47M 19.09M 36.19M 2.43B 36.8M 246M 95.52M 1.19B 95.79M 93.71M 4.1B 68.44M 59.8M 54.91M 51.21M 97.08M 6.52B 98.72M 661M 256M 3.2B 257M 251M 11.01B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
26-07-02 US$5.600 +1.82% 149,552
26-07-01 US$5.500 +7.00% 332,198
26-06-30 US$5.140 -13.47% 414,999
26-06-29 US$5.940 +1.37% 343,571
26-06-26 US$5.860 +11.62% 791,353
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.600USD
Average target price
11.17USD
Spread / Average Target
+99.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock